<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02955615</url>
  </required_header>
  <id_info>
    <org_study_id>2016-002</org_study_id>
    <secondary_id>2016-000488-17</secondary_id>
    <nct_id>NCT02955615</nct_id>
  </id_info>
  <brief_title>ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)</brief_title>
  <acronym>LUPIL-2</acronym>
  <official_title>A Phase II, Multi-centre, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iltoo Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iltoo Pharma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of ILT-101 (human
      recombinant interleukin 2 (IL-2)) in patients with moderate to severe systemic lupus
      erythematosus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interleukin 2 (IL-2) plays an important role on immune homeostasis by acting on T
      lymphocytes. In systemic lupus erythematosus, there is a so called &quot;insufficiency&quot; in a
      subpopulation of T lymphocytes, the regulatory T cells (Tregs) leading to altered immune
      balance between regulatory and effector T cells. These cells seem to play a major role in the
      physiopathology of the disease. Many researches enlighten the fact that this Tregs/Teffs
      balance can be restored by administering low dose of IL-2. It is thus assumed that treatment
      with low dose of IL-2 may impact positively the progression of the disease and thus help
      patients improving their clinical outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SRI-4 (SLE responder index)</measure>
    <time_frame>at week 12</time_frame>
    <description>Number of participants with SRI-4</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>From baseline up to week 24 or 36</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants able to reduce oral steroid dose of 25 and 50%</measure>
    <time_frame>From baseline to week 12 or 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anti ds-DNA by immunology-based assay</measure>
    <time_frame>From baseline to week 12 or 24</time_frame>
    <description>Change in anti-dsDNA as compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>%Tregs</measure>
    <time_frame>From baseline to week 12 or 24</time_frame>
    <description>% change in Tregs as compared to baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <arm_group>
    <arm_group_label>ILT-101</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subcutaneous administrations for 3 to 6 months according to clinical responder status at week 12</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subcutaneous administrations for 3 to 6 months according to clinical responder status at week 12</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ILT-101</intervention_name>
    <description>Induction phase followed by weekly administrations of ILT-101 on top of SLE background therapy.
SLE background therapy includes ...</description>
    <arm_group_label>ILT-101</arm_group_label>
    <other_name>Low dose IL-2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Induction phase followed by weekly administrations of placebo on top of SLE background therapy.
SLE background therapy includes ...</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed diagnosis of SLE

          -  Active SLE

          -  On stable background therapy for 1 month

          -  Using highly effective contraception

        Exclusion Criteria:

          -  Serious organ failure (renal functional impairment, severe central nervous system
             manifestations, severe heart failure, liver failure)

          -  Any clinical evidence of active chronic infection HIV, hepatitis B, hepatitis C

          -  Clinical significant pleuritis or pericarditis

          -  Type1 Diabetes and/or CROHN's disease

          -  Use of Benlysta (belimumab) in the past 4 weeks

          -  Use of Rituximab in the past 6 months

          -  Vaccination with live attenuated virus in the last month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Klatzmann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique Hôpitaux de Paris (AP-HP)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeremie MARIAU</last_name>
    <email>j.mariau@iltoopharma.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hietzing Hospital Wien</name>
      <address>
        <city>Wien</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zimmermann</last_name>
      <phone>+43 (0)1-80110-3174</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>AKH Wien</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scheinecker</last_name>
      <phone>+43 (0)1-40400-54140</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment</name>
      <address>
        <city>Pleven</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shimbova</last_name>
      <phone>+359888690272</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital for Active Treatment</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Batalov</last_name>
      <phone>+359888370497</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Center</name>
      <address>
        <city>Smolyan</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Petrova</last_name>
      <phone>+359879944030</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stoilov</last_name>
      <phone>+359887312219</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Limal</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hachulla</last_name>
      <phone>+33 (0)3 20 44 42 96</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Européen</name>
      <address>
        <city>Marseille</city>
        <zip>13003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiche</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Pitié Salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cacoub</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Haut Lévèque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viallard</last_name>
      <phone>+33 (0)5 57 65 64 83</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gottenberg</last_name>
      <phone>+33 (0)3 88 12 79 53</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charité</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexander</last_name>
      <phone>+49 30 450 513137</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johann Wolfgang Goethe-Universität</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60528</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Behrens</last_name>
      <phone>+49 (0)3419 713 263</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Leipzig AöR</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierer</last_name>
      <phone>+49 (0)3419 713 263</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <zip>23562</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Humrich</last_name>
      <phone>+49 (0)451 500 2368</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Osp. Univ. Seconda Università di Napoli</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valentini</last_name>
      <phone>0039 081 5666746</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario di Padova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Doria</last_name>
      <phone>0039 049 8212190</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Umberto I</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Conti</last_name>
      <phone>0039 0649974640</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cap research</name>
      <address>
        <city>Phoenix</city>
        <country>Mauritius</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rouzier</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital AmeriMed Cons.</name>
      <address>
        <city>Cancun</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Garcia</last_name>
      <phone>(998)881-3403</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Investigación y Biomedicina</name>
      <address>
        <city>Chihuahua</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pacheco Tena</last_name>
      <phone>526144373003</phone>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad de mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Medrano Ramirez</last_name>
      <phone>525555334180</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Integral en Reumatología S.A. de C.V.</name>
      <address>
        <city>Guadalajara</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Avila Armengol</last_name>
      <phone>523335859799</phone>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>León</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Morales Torres</last_name>
      <phone>52477 7145559</phone>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Tijuana</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Villasenor</last_name>
      <phone>52664 6351839</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Prof. Doutor Fernando Fonseca</name>
      <address>
        <city>Amadora</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delgado Alves</last_name>
      <phone>351962463749</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de Lisboa Ocidental</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pimentel Santos</last_name>
      <phone>00351 917 305 093</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Lisboa Norte</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maciera</last_name>
      <phone>00351 217 931 339</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar do Porto</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faria</last_name>
      <phone>00351 919 056 534</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neomed</name>
      <address>
        <city>Braşov</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stoicescu</last_name>
      <phone>40722530460</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Euroclinic Hospital</name>
      <address>
        <city>Bucuresti</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chicos</last_name>
      <phone>40745088514</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sf. Maria Hospital</name>
      <address>
        <city>Bucuresti</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Berghea</last_name>
      <phone>40723236258</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Vall D'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cortes</last_name>
      <phone>34934894171</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carreira</last_name>
      <phone>91 779 27 57</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Parc Tauli de Sabadell</name>
      <address>
        <city>Sabadell- Barcelona</city>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moreno</last_name>
      <phone>937231010 ext 24065</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roman</last_name>
      <phone>34961244076</phone>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Bulgaria</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Mauritius</country>
    <country>Mexico</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2016</study_first_submitted>
  <study_first_submitted_qc>November 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2016</study_first_posted>
  <last_update_submitted>May 31, 2017</last_update_submitted>
  <last_update_submitted_qc>May 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

